New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 24, 2014
08:08 EDTNVS, MMMEMA committee recommends approval for 3M rivastigmine patch
The EMA's Committee for Medicinal Products for Human Use adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Rivastigmine transdermal patches intended for symptomatic treatment of mild to moderately severe Alzheimer's dementia. The applicant for this medicinal product is 3M Health Care (MMM). Rivastigmine 3M Health Care Ltd is a generic of Novartis' (NVS) Exelon.
News For MMM;NVS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 1, 2015
05:16 EDTNVSNovartis division Alcon receives CE Mark for AcryS of IQ Aspheric IOL
Subscribe for More Information
June 30, 2015
05:32 EDTNVSNovartis launches first Apple Watch app for visually impaired people
Novartis Pharmaceuticals (NVS) announced the release of new features for its ViaOpta applications, and the extension for use with smart watches. The discreet, hands-free nature of using ViaOpta app with wearable devices, such as Apple Watch (AAPL) and Android Wear (GOOG), provides users with an experience that seamlessly fits into their existing routines allowing those with visual impairments to navigate daily life with even greater ease.
June 29, 2015
08:35 EDTNVSAnacor announces amendment to KERYDIN commercialization agreement
Subscribe for More Information
05:15 EDTNVSNovartis acquires Spinifex Pharmaceuticals, terms not disclosed
Novartis announced that it has entered into an agreement to acquire Spinifex Pharmaceuticals. Spinifex Pharmaceuticals is a U.S. and Australian-based, privately held development stage company, focused on developing a peripheral approach to treat neuropathic pain such as EMA401, a novel angiotensin II Type 2 receptor, or AT2R, antagonist. Financial terms were not disclosed.
June 26, 2015
07:44 EDTNVSNovartis drug Farydak recommended by CHMP for EU approval
Subscribe for More Information
June 25, 2015
17:00 EDTMMM3M files patent infringement lawsuit in Germany for dental ceramic technology
3M has filed a patent infringement lawsuit in Düsseldorf, Germany, against Zirkonzahn Deutschland GmbH located in Neuler, Germany, and Zirkonzahn SRL located in Gais, South Tyrol, Italy. The lawsuit alleges infringement of 3M’s European Patent No. 1 154 969 B2 by using Zirkonzahn’s instructions for sintering of Zirkonzahn’s zirconia blocks. 3M’s patented technology enables dimensionally precise sintering of dental ceramics.
14:02 EDTNVSNovartis initiated with a Buy at HSBC
Price target CHF 115.
June 23, 2015
09:03 EDTMMM3M to buy Capital Safety from KKR in deal valued at $2.5B
3M (MMM) announced it has entered into a definitive agreement to acquire Capital Safety from KKR (KKR) for a total enterprise value of $2.5B, including the assumption of approximately $700M of debt, net of cash acquired. The business employs approximately 1,500 people worldwide and is headquartered in Bloomington, Minnesota. On a GAAP reported basis, 3M estimates the acquisition to be 4c dilutive to earnings in the first 12 months following completion of the transaction. Excluding purchase accounting adjustments and anticipated one-time expenses related to the transaction and integration, 3M estimates the acquisition to be 12c accretive to earnings over the same period. The transaction is expected to close in the third quarter, subject to customary closing conditions and regulatory approvals. 3M will finance the transaction with existing cash, a portion of which will come from outside the U.S.
June 22, 2015
14:31 EDTMMM3M files patent infringement suit in Korea against LMS Co. Ltd.
3M Innovative Properties Co. and 3M Korea Ltd. filed a patent infringement lawsuit on June 19 in the Seoul Central District Court against LMS Co. Ltd. The suit alleges that certain LMS Co. Ltd. light management film package products, including a light management film package product sold under the product name of “XLAS,” infringe 3M’s Korean Patent No. 1,074,570 titled "Method for Stacking Surface Structured Optical Films." 3M’s microreplicated stacked prism films, including 3M Advanced Structured Optical Composites (ASOC), are integrated into LCD displays. The prism films direct light to enable a thinner and more energy-efficient electronic display.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use